Clinical trial
Rationale and Design for Shiga Microalbuminuria Reduction Trial
NCT00202618 · Shiga University, Other · Unknown status
Key facts
| NCT number | NCT00202618 |
|---|---|
| Title | Rationale and Design for Shiga Microalbuminuria Reduction Trial |
| Official title | The Reduction of Microalbuminuria in Japanese Hypertensive Subjects With Type 2 Diabetes Mellitus Treated With Valsartan or Amlodipine: Study Design for the Shiga Microalbuminuria Reduction Trial (SMART) |
| Lead sponsor | Shiga University, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Diabetes Mellitus, Albuminuria |
| Intervention type | Drug |
| Interventions | Valsartan, Amlodipine |
| Enrollment | 160 |
| Start date | Dec 1, 2003 |
| Completion | Jun 1, 2006 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 27, 2006 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: